Medifast
MED
297 hedge funds and large institutions have $2.05B invested in Medifast in 2021 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 89 increasing their positions, 113 reducing their positions, and 43 closing their positions.
400% more funds holding in top 10
Funds holding in top 10: 1 → 5 (+4)
7% more capital invested
Capital invested by funds: $1.93B → $2.05B (+$126M)
5% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 43
0% more funds holding
Funds holding: 296 → 297 (+1)
0.9% less ownership
Funds ownership: 85.24% → 84.34% (-0.9%)
21% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 113
42% less call options, than puts
Call options by funds: $14.1M | Put options by funds: $24.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$28.8M |
| 2 |
GEH
General Equity Holdings
Brooklyn,
New York
|
+$21.1M |
| 3 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$12.5M |
| 4 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$11.5M |
| 5 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$11.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Candlestick Capital Management
Greenwich,
Connecticut
|
-$21M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.1M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$13.4M |
| 4 |
Millennium Management
New York
|
-$9.31M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$9.2M |
MED Hedge Fund Activity: Q4 2021 in Review
297 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2021, worth a combined $2.05B — up 6.5% from $1.93B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new MED positions and 43 closed out — a net gain of 2 holders — while 89 added to existing stakes and 113 trimmed.
The largest buyer was BlackRock, adding an estimated $28.8M. The largest seller was Candlestick Capital Management, exiting entirely with an estimated $21M sold.
- 297 institutional investors held Medifast (MED) as of Q4 2021, up from 296 in Q3 2021.
- Funds reported $2.05B of Medifast stock for Q4 2021, up 6.5% quarter-over-quarter.
- 45 funds opened new Medifast positions in Q4 2021 and 43 closed out, a net change of +2 holders.
- The largest Medifast buyer in Q4 2021 was BlackRock, an estimated $28.8M added.
- The largest Medifast seller in Q4 2021 was Candlestick Capital Management, an estimated $21M sold.
Based on aggregated 13F filings for Q4 2021.